Pea, Federico, Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 177 - 189 [articolo]
Cojutti P.; Sartor A.; Bassetti M.; Scarparo C.; Pea F., Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2018, 14, pp. 238 - 241 [articolo]
Pea F; Lewis RE, Overview of antifungal dosing in invasive candidiasis, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2018, 73, pp. i33 - i43 [articolo]
Pea F., Pharmacokinetics and drug metabolism of antibiotics in the elderly, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2018, 14, pp. 1087 - 1100 [articolo]
Cojutti P.; Pai M.P.; Pea F., Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 989 - 1000 [articolo]
Cojutti P.G.; Lugano M.; Righi E.; Della Rocca G.; Bassetti M.; Hope W.; Pea F., Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1449 - 1459 [articolo]
Concia E, Viscoli C, Del Bono V, Giannella M, Bassetti M, De Rosa GF, Durante Mangoni E, Esposito S, Giusti M, Grossi P, Menichetti F, Pea F, Petrosillo N, Tumbarello M, Stefani S, Venditti M, Viale P, The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts, «JOURNAL OF CHEMOTHERAPY», 2018, 30, pp. 157 - 171 [articolo]
Tangden T.; Cojutti P.G.; Roberts J.A.; Pea F., Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 1399 - 1405 [articolo]
Pea F.; Cojutti P.G.; Baraldo M., A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2017, 121, pp. 303 - 308 [articolo]
Pea F., β-blockers and diltiazem combination—bear in mind the risk of heart block, «JAMA INTERNAL MEDICINE», 2017, 177, pp. 1543 - 1544 [replica/breve intervento]
Bassetti M.; Pecori D.; Cojutti P.; Righi E.; Pea F., Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2017, 13, pp. 1193 - 1200 [articolo]
Cojutti P.; Giangreco M.; Isola M.; Pea F., Limited sampling strategies for determining the area under the plasma concentration–time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2017, 50, pp. 23 - 28 [articolo]
Pea F.; Della Siega P.; Cojutti P.; Sartor A.; Crapis M.; Scarparo C.; Bassetti M., Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2017, 49, pp. 255 - 258 [articolo]
Ramos-Martin V.; Johnson A.; McEntee L.; Farrington N.; Padmore K.; Cojutti P.; Pea F.; Neely M.N.; Hope W.W., Pharmacodynamics of teicoplanin against MRSA, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2017, 72, pp. 3382 - 3389 [articolo]
Cojutti P.G.; Candoni A.; Ramos-Martin V.; Lazzarotto D.; Zannier M.E.; Fanin R.; Hope W.; Pea F., Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2017, 72, Article number: dkx140, pp. 2342 - 2350 [articolo]
